Mito Target

  • Choose your Language:

    • Français
    • , 
    • Deutsch
    • , 
    • Español
    • , 
    • Nederlands
  • Home
    • Public & Patients
    • Scientists & Physicians
    • Institutions & Investors

You are here / Home » Public & Patients

Mito Target News RSS

The information provided in this web site is intended to educate the reader about certain medical conditions and certain possible treatments. It is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. If you believe you, suffer from the conditions described herein, please see your health care provider. Do not attempt to treat yourself or anyone else without proper medical supervision.
Read the Full Disclaimer

Yes, I have read the Full Disclaimer

Public & Patients

What is ALS?

What is ALS? What are clinical trials? FAQs & Support

Discover more

What are Clinical Trials?

A clinical trial is one of the final stages of a long and careful pharmaceutical research process.

Get Support

Find out more on the disease and get support

Latest News

Disappointing results of olesoxime clinical trial announced

13 December 2011

13 December 2011 Results from a recent clinical trial into motor neurone disease (MND), involving people with MND in England, have been announced and show the trial drug to be ineffective a

Trophos announces results of phase 3 study of olesoxime in ALS

13 December 2011

MARSEILLE, FRANCE – December 13 2011. Trophos SA announces today the results from the phase 3 study of Trophos’ lead compound, olesoxime, in 512 patients with ALS.

Trophos announces final patient completion of pivotal phase three efficacy study of olesoxime in Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease)

22 September 2011

Top-line results expected fourth quarter 2011   Marseille, France, September 22, 2011 - Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discov

See all News Items

  • Public & Patients
    • What is ALS?
    • What are Clinical Trials?
    • Get Support
    • MitoTarget Trial
    • Ask the Specialists
  • Scientists & Physicians
  • Institutions & Investors
  • News
  • Contact Us
  • Choose your Language:

    • Français
    • , 
    • Deutsch
    • , 
    • Español
    • , 
    • Nederlands
  • © Copyright 2010
  • Home
    • Public & Patients
    • Scientists & Physicians
    • Institutions & Investors

The MitoTarget project is supported by the European Union under the 7th Framework Programme for RTD - Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388

Seventh Framework Programme European Union